2020
DOI: 10.3389/fped.2020.00532
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial Oxygen Monitoring During Surgical Repair of Congenital Diaphragmatic Hernia or Esophageal Atresia: A Feasibility Study

Abstract: Current monitoring techniques in neonates lack sensitivity for hypoxia at cellular level. The recent introduction of the non-invasive Cellular Oxygen METabolism (COMET) monitor enables measuring in vivo mitochondrial oxygen tension (mitoPO 2 ), based on oxygen-dependent quenching of delayed fluorescence of 5-aminolevulinic acid (ALA)-enhanced protoporphyrin IX. The aim is to determine the feasibility and safety of non-invasive mitoPO 2 monito… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 49 publications
0
5
0
Order By: Relevance
“…Interestingly, an unexpected high incidence of adverse events was seen in our study, since 100% of the healthy volunteers developed local adverse events during the measurements. Previously reported incidence of adverse events of mitoPO 2 measurements was 45% in healthy volunteers [ 31 ], while minimal to no adverse events have been reported in mitoPO 2 measurements with critically ill patients [ 15 , 20 , 32 ]. As in previous studies, the adverse events were present at the measurement sites up to one month after the last mitoPO 2 measurement.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Interestingly, an unexpected high incidence of adverse events was seen in our study, since 100% of the healthy volunteers developed local adverse events during the measurements. Previously reported incidence of adverse events of mitoPO 2 measurements was 45% in healthy volunteers [ 31 ], while minimal to no adverse events have been reported in mitoPO 2 measurements with critically ill patients [ 15 , 20 , 32 ]. As in previous studies, the adverse events were present at the measurement sites up to one month after the last mitoPO 2 measurement.…”
Section: Discussionmentioning
confidence: 99%
“…MitoPO 2 measurement at the anterior chest wall in supine position strengthened the stabilization of the measurement probe despite respiratory movements of the chest wall. A double-sided plaster for fixation of the measurement probe is now handed out by the manufacturer to further minimise the effect of movement artefacts of the measurement probe on measurement variability [ 14 , 32 ]. Despite no availability of double-sided plaster during the measurements in this study, the within-subject variability over time was within acceptable limits as described in previous studies [ 15 , 17 ].…”
Section: Discussionmentioning
confidence: 99%
“…Further pre-clinical studies consisted of (calibration) studies in healthy volunteers, after which the focus shifted to clinical studies [20,26]. Since the introduction of the clinical COMET system in 2016, mitochondrial oxygenation has been analyzed in neonates and in neurosurgical, cardiothoracic surgery, COVID-19, and sepsis patients [27][28][29][30]. A depiction of the COMET system can be seen in Figure 2.…”
Section: Mitopo 2 Measurementsmentioning
confidence: 99%
“…Since the introduction of COMET ® it has been utilized in several clinical studies. To date, the COMET ® has been used in studies performed with critically ill patients [ 21 , 22 ], healthy volunteers [ 23 ] and surgical newborns [ 24 ]. Additionally, Ubbink [ 10 ] and Harms [ 25 ] et al have presented several case reports wherein mitochondrial oxygenation (mitoPO 2 ) measurements are described amid hemodynamically unstable surgical situations.…”
Section: Introductionmentioning
confidence: 99%